IV and injection therapy in a clinical setting

NAD+ Injections vs IV Therapy: Differences, Evidence, Cost & Practical Considerations

July 21, 20263 min read

NAD+ has become one of the most recognizable names in longevity medicine. Clinics offer intravenous infusions, injections and precursor supplements, often with claims involving energy, cognition, recovery and healthy aging.

The short answer: IV and subcutaneous delivery differ in administration, exposure and convenience, but strong clinical evidence showing that one route produces superior long-term health or longevity outcomes is limited. Marketing claims should not be confused with established outcomes.

What is NAD+?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme involved in redox reactions, cellular energy metabolism and enzymes such as sirtuins and PARPs.

Its biological importance is well established. The harder question is whether raising NAD+ through a particular therapy improves a specific clinical outcome in humans.

IV NAD+ vs subcutaneous NAD+

Feature IV NAD+ Subcutaneous NAD+
Administration Infused into a vein Injected into subcutaneous tissue
Typical setting Clinic or supervised infusion setting May be more convenient depending on prescribed protocol
Delivery Direct intravenous exposure Absorption from subcutaneous tissue
Time commitment Usually greater Usually shorter
Evidence for longevity outcomes Limited Limited

A pharmacologic difference between routes does not by itself establish a meaningful difference in long-term clinical benefit.

What does NAD+ actually do in the body?

NAD+ participates in conversion of nutrients into usable cellular energy and acts as a substrate for enzymes involved in DNA repair and cellular signaling.

That is why NAD biology is a major area of aging research. But the statement “NAD+ is essential to cellular function” does not prove that an NAD+ infusion reverses aging, prevents disease or improves lifespan.

What should patients ask?

Before choosing a route, ask:

  1. What is the specific goal of treatment?
  2. What human evidence supports NAD+ for that goal?
  3. Why is IV or subcutaneous delivery being recommended?
  4. What side effects should I expect?
  5. Are there medical conditions or medications that change the risk?
  6. How will we decide whether treatment is helping?

Axiom Healthspan offers clinician-reviewed longevity and NAD+ programs for patients interested in discussing these questions within a broader health-optimization plan.

Frequently asked questions

Is IV NAD+ proven to reverse aging?

No. NAD+ biology is relevant to aging research, but there is no basis for guaranteeing that IV NAD+ reverses biological aging or extends lifespan.

Is an injection automatically better absorbed than an oral supplement?

Different molecules and precursor forms have different pharmacokinetics. “Better absorbed” also does not necessarily mean “better clinical outcome.”

Why do NAD+ infusions sometimes take longer?

Infusion rate and tolerability can influence administration. Specific protocols should be determined by the treating clinical team.

Which NAD+ route is best?

There is no universally superior route established for every longevity goal. Convenience, clinical rationale, tolerability and available evidence should guide the discussion.

Bottom line

NAD+ is scientifically important, but the clinical evidence for wellness and longevity protocols is still developing. Choose a delivery method based on an individualized clinical discussion rather than claims that one route is categorically superior.

Sources

Educational information only and not medical advice.

Back to Blog